The global respiratory care devices market is likely to expand at a CAGR of 10.1% during the estimated timeframe on the back of increasing screening of respiratory diseases. Additionally, the respiratory care devices have utilized the treatment, diagnosis, assessment, and rising growing focus of care of patients suffering from respiratory devices..
Segmentation:
Based on the therapeutic devices, the market is segmented into pap devices, ventilators, masks, nebulizers, oxygen concentrators, humidifiers, inhalers, reusable resuscitators, oxygen hoods, and nitric oxide delivery units.
Based on the monitoring devices, the market is segmented into pulse oximeter sensors, pulse oximeters, pulse oximeter equipment, analyzers, and capnographs.
Based on the diagnostic devices, the market is segmented into spirometers, peak flow meters, polysomnography (PSG) devices, and other diagnostic devices.
Based on the accessories & consumables, the market is segmented into disposable masks, tracheostomy tubes, disposable resuscitators, nasal cannulas, and other.
Based on the application, the market is segmented into sleep apnea, chronic obstructive pulmonary disease (COPD), asthma, infectious diseases, and other diseases.
Based on the end user, the respiratory care devices market is segmented into hospitals, ambulatory care, clinics, home care, and others.
Regional Analysis:
Regionally, the Respiratory Care Devices Market is segmented intotheAmericas, Europe, Asia Pacific, and the Middle East and Africa. Of these, the Americas are estimated to remain dominant in the global respiratory care devices market in the coming period owing to a surge in the adoption of advanced technologies in the healthcare industry and presence of the favorable reimbursement policies. Additionally, numbers from the Centers for Disease Control and Prevention (CDC) suggested that the deaths due to chronic respiratory diseases were 155,041 in 2015, and the number of people suffering from chronic bronchitis was 8.9 million in the U.S. only, which is likely to rise in coming years. Thus, the market for respiratory care devices in the region is likely to be benefited from the increase in the prevalence of the disease.
Europe is anticipated to hold the second-largest share in the revenue of the global respiratory care devices market owing to the increasing number of surgeries coupled with increasing frequency of diabetic patients in the region. Additionally, increasing investment for the adoption of advanced treatment devices and procedures is likely to benefit market growth in the coming years. However, the Asia Pacific is estimated to be the fastest-growing region owing to increasing respiratory diseases and disorders in the region. Further, the factor benefiting market growth include an increase in the adoption of several treatments and facilities in hospitals. The factors such as increasing investment for improving healthcare infrastructure, optimal treatment facilities, increasing disposable income and affordability of patients, and surge in medical tourism in the region are benefiting the market growth. Additionally, rising government support for raising public awareness about the respiratory diseases and availability of newer devices.
Global Respiratory Care Devices Market: Therapeutic devices (PAP Devices), Monitoring devices (Pulse Oximeters), Diagnostic devices (Spirometers), Accessories & Consumables (Disposable Masks), and Application (Asthma and Others)—Global Forecast till 2023 @https://www.marketresearchfuture.com/reports/respiratory-care-devices-market-6517
Market Key Players
Philips Healthcare (Netherlands), ResMed, Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Becton, Dickinson and Company (US), Chart Industries, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland) in the report on the same market.
Related Healthcare News
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
Ailments such as tuberculosis, chronic bronchitis, asthma, acute and chronic pulmonary diseases are highly dependent on respiratory care devices, and the rise of these ailments globally will fuel development of the respiratory care devices in the forecast period.Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6517 Segmentation:The respiratory care devices market is segmented by therapeutic devices, monitoring devices, diagnostic devices, accessories & consumables, applications, end users, and region.
Based on the application, the market is segmented into sleep apnea, chronic obstructive pulmonary disease (COPD), asthma, infectious diseases, and other diseases.Based on the end user, the respiratory care devices market is segmented into hospitals, ambulatory care, clinics, home care, and others.Regional Analysis:Regionally, the respiratory care devices market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
Of these, the Americas are estimated to remain dominant in the global respiratory care devices market in the coming period owing to a surge in the adoption of advanced technologies in the healthcare industry and presence of the favorable reimbursement policies.
Additionally, numbers from the Centers for Disease Control and Prevention (CDC) suggested that the deaths due to chronic respiratory diseases were 155,041 in 2015, and the number of people suffering from chronic bronchitis was 8.9 million in the U.S. only, which is likely to rise in coming years.
However, the Asia Pacific is estimated to be the fastest-growing region owing to increasing respiratory diseases and disorders in the region.
Further, the factor benefiting market growth include an increase in the adoption of several treatments and facilities in hospitals.
An above-average rise at 4.0% volume CAGR is foreseen for the syringes & cannulas market over the period of forecast, 2018 to 2028, by a new Fact.MR study.
Pervasiveness of syringes in terms of the market volume share continues to prevail, whereas the growth rate will also remain higher for these products, compared to cannulas, through 2028.
Additionally, majority volume share of worldwide syringes sales is estimated to remain hinged at disposable variants.The global syringes & cannulas market analysis report also provides an in-detailed analysis of the overall vendor landscape.
Furthermore, it takes into consideration the existing development, past events, and recent trends to provide a strong and unbiased opinion on the future direction in which these leading companies will be heading into.
To back its opinion, the research report covers all the factors and events such as mergers, acquisitions, takeovers, joint ventures, and strategic alliances.
It also analyzes the entry barriers and overall intensity of the competition in the global syringes & cannulas market.
Oxygen Therapy Equipment Market: By Product (Oxygen Source Equipment, Oxygen Delivery Devices), Portability (Stationary Oxygen Therapy Devices, Portable Oxygen Therapy Devices), Application (Cystic Fibrosis, Pneumonia) — Global Forecast till 2027Market HighlightsThe global oxygen therapy equipment market is expected to register a growth of significant CAGR 8.9% during the forecast period (2018–2023).
Increasing prevalence of respiratory diseases, rising healthcare expenditure, growing geriatric population and favorable reimbursement policies are the drivers for the global oxygen therapy device market.
The oxygen concentrators are further segmented in to portable oxygen concentrators and fixed oxygen concentrators.
The oxygen delivery devices are segmented in to bag valve masks, non-rebreather masks, venturi masks, oxygen masks, nasal cannulas and other devices.
On the basis of end users, the market has been classified as home care settings, hospitals, ambulatory surgical centers & physician offices and others.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7516Regional AnalysisNorth America accounted for the largest share of the global oxygen therapy equipment market owing to high R investments and trials pertaining to oxygen therapy.
Awareness programs and quality assurance of diagnostic procedures have added importance in the developing economies of Korea, Taiwan, China, Sri Lanka and India since the last few years.The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.Key PlayersSome of the key players in the global oxygen therapy equipment market are Philips Healthcare (A Division of Koninklijke Philips N.V.), Linde Healthcare (A Division of Linde Group), Becton Dickinson and Company, Taiyo Nippon Sanso Corporation, Smiths Medical (A Division of Smiths Group PLC), Drägerwerk AG & Co. KGaA, Teleflex Incorporated, Invacare Corporation, Fisher & Paykel Healthcare Corporation Limited, Allied Healthcare Products Inc., Esex Industries, Inc., Messer Medical Austria GmbH, Medicop D.O.OTable Of Contents:Chapter 1.
Global Vocal Cord Paralysis Market: Information by Type (Unilateral and Bilateral), Treatment (Voice Therapy and Surgery) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027Market SnapshotIn the recent study, Market Research Future (MRFR) has asserted that the global vocal cord paralysis market is likely to expand at a CAGR of 3.8%, amassing the market value if USD 2,920.2 million by 2023.The increased incidence of larynx, neck, and head cancers are estimated to be the most substantial factor driving the global vocal cord paralysis market 2020.
Further, the rise in expenditure on healthcare, particularly in developing countries, has played a vital role in stimulating the market considerably.
Besides, the favorable reimbursement policies have encouraged the patients to opt for the treatment, which is predicted to further escalate the market growth across the globe.Contrarily, the enormous price involved in the treatment of the diseases is projected to be a substantial factor obstructing the market.
Despite the impeding factor, the global market is anticipated to grow owing to the development in treatment procedures such as laryngoscopy, endoscopy, and other methods that allow fast diagnosis of the condition, which assists in combating the constraining factor.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5079 Market SegmentationThe segment analysis of the global vocal cord paralysis market is performed on the basis of type and treatment.The type-based segments of the global vocal cord paralysis market are unilateral and bilateral.
On the other hand, the bilateral segment is projected to expand at a CAGR of 3.80 during the forecast period.The treatment-based segments of the global vocal cord paralysis market are voice therapy and surgery.
The voice therapy segment is anticipated to record a CAGR of 3.4%, amassing the market value of USD 1,848.7 million by 2023.
The global dietary supplements market size is expected to showcase an exponential growth by reaching USD 117.92 billion by 2027 while exhibiting a CAGR of 9.8% between 2020 and 2027.
This is attributable to the increasing demand for personalized dietary supplements and the rising prevalence of chronic diseases such as diabetes, hypertension, high cholesterol levels, and other heart ailments.
This information is published by Fortune Business Insights, in its latest report, titled, “Dietary Supplements Market Size, Share & COVID-19 Impact Analysis, By Type (Vitamins, Minerals, Enzymes, Fatty Acids, Proteins, and Others), Form (Tablets, Capsules, Liquids, and Powders), and Regional Forecasts, 2020 – 2027.” The report further mentions that the market was worth USD 48.22 billion in 2019 and is likely to rise in the forthcoming years.Surging Demand for Immunity Boosting Diet amid COVID-19The COVID-19 outbreak has put tremendous pressure on healthcare services.
The government agencies have advised the citizens to follow a healthy and nutritious diet regime to fight the disease.
The global market is expected to experience positive growth in the near future.Dietary supplements are products that supplement consumers with the necessary nutrients that are sourced from synthetic or natural food sources.
These supplements are provided in the form of capsules, pills, tablets, or liquids.
For healthcare organizations in every part of the world, assessing the growth of global medical tapes market is essential for planning and managing medical supplies beforehand.
Clinics, ambulatory centers, and hospitals continue to adopt the latest range of surgical tapes in order to retain the faith of patients in such preliminary medical procedures.
According to a report developed by Research Report Insights (RRI), titled “Global Market Study on Medical Tapes: Hospitals End User Segment to Retain Market Dominance Through 2024,” the global medical tapes market is anticipated to expand at a steady CAGR of 5.8% and reach market value of US$ 1,757.2 million by the end of forecast period 2016-2024.
Adhesives applied to such pressure sensitive tapes are hypoallergenic – skin adhering – and do not cause skin damages upon removal.
The report has illustrated factors that either drive the growth of the global market or curb the use of medical tapes.
Discordantly, factors that inhibit the market’s growth include growing availability of advanced wound management products and increasing awareness of medical adhesive related skin injuries (MARSI).
